Andrew G Robinson
Overview
Explore the profile of Andrew G Robinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
6892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Krzyzanowska M, Julian J, Gu C, Powis M, Li Q, Enright K, et al.
BMJ
. 2021 Dec;
375:e066588.
PMID: 34880055
Objective: To evaluate the effectiveness of remote proactive management of toxicities during chemotherapy for early stage breast cancer. Design: Pragmatic, cluster randomised trial. Setting: 20 cancer centres in Ontario, Canada,...
12.
Goldie C, Nguyen P, Robinson A, Goldie C, Kircher C, Hanna T
Curr Oncol
. 2021 Sep;
28(5):3297-3315.
PMID: 34590598
Objectives: (1) To describe EOL health services quality indicators and timing of palliative care consultation provided to patients dying of NSCLC. (2) To examine associations between aggressive and supportive care...
13.
Mansfield A, Herbst R, de Castro Jr G, Hui R, Peled N, Kim D, et al.
JTO Clin Res Rep
. 2021 Sep;
2(8):100205.
PMID: 34590048
Introduction: We retrospectively evaluated outcomes in patients with programmed death-ligand 1 (PD-L1)-positive non-small-cell lung cancer (NSCLC) to determine whether baseline (i.e., at study enrollment) brain metastases were associated with the...
14.
Gyawali B, Griffiths R, Robinson A, McInnes M, Bedard P, Booth C
Can Urol Assoc J
. 2021 Sep;
16(2):26-33.
PMID: 34582333
Introduction: Imaging is an integral component of active surveillance (AS) following orchiectomy for stage 1 non-seminoma (NSGCT) and seminoma germ cell tumors. In this population-based study, we describe use of...
15.
Kartolo A, Holstead R, Duran I, Robinson A, Vera-Badillo F
Urology
. 2021 Aug;
157:8-14.
PMID: 34461142
Objective: To define the impact of first-line dual therapy involving immune checkpoint inhibitors (ICI) on survival outcomes in patients with advanced renal cell carcinoma (aRCC) of International Metastatic RCC Database...
16.
Khalid S, Basulaiman B, Emack J, Booth C, Duran I, Robinson A, et al.
Eur Urol Open Sci
. 2021 Aug;
21:61-68.
PMID: 34337469
Background: Fibroblast growth factor receptor 3 (FGFR3) mutations have been implicated in urothelial tumorigenesis. FGFR3 inhibitors are being explored in clinical trials. Objective: We aimed to study the association between...
17.
Reck M, Rodriguez-Abreu D, Robinson A, Hui R, Csoszi T, Fulop A, et al.
J Clin Oncol
. 2021 Apr;
39(21):2339-2349.
PMID: 33872070
Purpose: We report the first 5-year follow-up of any first-line phase III immunotherapy trial for non-small-cell lung cancer (NSCLC). KEYNOTE-024 (ClinicalTrials.gov identifier: NCT02142738) is an open-label, randomized controlled trial of...
18.
Robinson A, Izard J, Vera-Badillo F
Eur Urol
. 2021 Mar;
80(2):123-126.
PMID: 33773874
For patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after an androgen receptor axis-targeted therapy and docetaxel, poly (ADP-ribose) polymerase (PARP) inhibitors and chemotherapy with cabazitaxel have shown promise. We...
19.
Hanna N, Robinson A, Temin S, Baker Jr S, Brahmer J, Ellis P, et al.
J Clin Oncol
. 2021 Feb;
39(9):1040-1091.
PMID: 33591844
Purpose: To provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC) with driver alterations. A guideline update for systemic...
20.
Raphael M, Gupta S, Wei X, Peng Y, Soares C, Bedard P, et al.
J Clin Oncol
. 2021 Jan;
39(7):779-786.
PMID: 33507821
Purpose: Testicular cancer survivors may experience mental illness as a consequence of their cancer diagnosis and treatment. Methods: All incident cases of testicular cancer treated with orchiectomy in Ontario, Canada...